US Patent Application No: 2003/0073,669

Number of patents in Portfolio can not be more than 2000

N-heterocyclic derivatives as NOS inhibitors

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

N-Heterocyclic derivatives of the formula (I): 1 are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing these compounds are also described herein.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
BERLEX LABORATORIES, INC.RICHMOND, CA80
PHARMACOPEIA DRUG DISCOVERY, INC.CRANBURY, NJ96

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arnaiz, Damian O El Sobrante, CA 35 203
Baldwin, John J Gwynedd Valley, PA 250 1402
Davey, David D El Sobrante, CA 51 460
Devlin, James J Foster City, CA 65 110
Dolle, Roland Ellwood III King of Prussia, PA 11 1
Erickson, Shawn David Leonia, NJ 48 150
McMillan, Kirk Trenton, NJ 21 44
Morrissey, Michael M Danville, CA 88 1194
Ohlmeyer, Michael HJ Plainsboro, NJ 9 92
Pan, Gonghua Groton, CT 26 36
Paradkar, Vidyadhar Madhav Somerville, NJ 20 33
Parkinson, John Martinez, CA 29 53
Phillips, Gary B Pleasant Hill, CA 61 542
Ye, Bin Moraga, CA 60 184
Zhao, Zuchun Pleasanton, CA 72 277

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
PHARMACOPEIA, LLC (1)
6,919,347 Bradykinin B1 receptor antagonists 0 2002

Full Text

 
loading....